0001104659-24-063414.txt : 20240520 0001104659-24-063414.hdr.sgml : 20240520 20240520161527 ACCESSION NUMBER: 0001104659-24-063414 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240516 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hochman David P CENTRAL INDEX KEY: 0001292834 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39421 FILM NUMBER: 24964650 MAIL ADDRESS: STREET 1: 15 WESTON HILL RD. CITY: RIVERSIDE STATE: CT ZIP: 06878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc. CENTRAL INDEX KEY: 0001814114 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 BUSINESS PHONE: 646-343-9298 MAIL ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2 DATE OF NAME CHANGE: 20200603 4 1 tm2414952-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-05-16 0 0001814114 Orchestra BioMed Holdings, Inc. OBIO 0001292834 Hochman David P C/O ORCHESTRA BIOMED HOLDINGS, INC. 150 UNION SQUARE DRIVE NEW HOPE PA 18938 1 1 0 0 See Remarks 0 Common Stock, par value $0.0001 per share ("Common Stock") 2024-05-16 4 A 0 2000 4.75 A 329502 I By the DPH 2008 Trust Common Stock 2024-05-17 4 A 0 3000 5.15 A 332502 I By the DPH 2008 Trust Common Stock 3140 I By the NSH 2008 Family Trust Common Stock 565498 D The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $5.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Chief Executive Officer and Chairperson /s/ Matthew R. Schob, Attorney-in-Fact 2024-05-20